Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Atherosclerosis
  • (-) = Hoorn, J.W.A. van der

Search results

  • RSS Feed
(1 - 5 of 5)
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
Landlinger, C.; Pouwer, M.G.; Juno, C.; Hoorn, J.W.A. van der; Pieterman, E.J.; Jukema, J.W.; ... ; Galabova, G. 2017
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
Article / Letter to editor
open access
innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising. A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Kühnast, S.; Fiocco, M.; Hoorn, J.W.A. van der; Princen, H.M.G.; Jukema, J.W. 2015
innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising. A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Article / Letter to editor
metadata only
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Kuhnast, S.; Fiocco, M.; Hoorn, J.W.A. van der; Princen, H.M.G.; Jukema, J.W. 2015
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Article / Letter to editor
metadata only
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
Kuhnast, S.; Tuin, S.J.L. van der; Hoorn, J.W.A. van der; Klinken, J.B. van; Simic, B.; Pieterman, E.; ... ; Princen, H.M.G. 2015
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
Article / Letter to editor
metadata only
Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice
Berbee, J.F.P.; Wong, M.C.; Wang, Y.N.; Hoorn, J.W.A. van der; Khedoe, P.P.S.J.; Klinken, J.B. van; ... ; Rensen, P.C.N. 2013
Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice
Article / Letter to editor
metadata only